A significant funding gap in the NHS rollout of the new Mounjaro weight-loss injection means that only a fraction of eligible people are likely to receive treatment, according to new research.

A tightly controlled human trial has found that ultra-processed foods can increase body fat and disrupt hormone levels even when calorie intake is identical to that of unprocessed meals.

Stressful life circumstances may disrupt communication between the brain and gut, increasing the likelihood of unhealthy food choices and raising the risk of obesity, two new studies suggest.

Weight-loss drugs could cut by half the risk of heart patients dying prematurely or being admitted to hospital, according to the largest study of its kind.

Fat cells could play a crucial role in fuelling certain breast cancer tumours, according to new research which may open the door to future treatments for one of the disease’s most aggressive forms.

Clearer labelling and tougher standards aim to give babies a healthier start in life

Women with obesity who take part in structured weight loss programmes before beginning IVF are 47 per cent more likely to conceive naturally, according to the largest review of evidence to date.

Childhood obesity rates in Leeds have fallen for the second consecutive year, according to new figures from Leeds City Council.

Supermarkets and food manufacturers in England will be asked to make it easier for customers to choose healthy options under new government plans aimed at tackling rising obesity rates.

Eating meals earlier in the day may help counteract genetic predisposition to obesity, according to new research led by scientists at the Complutense University of Madrid.

A major international study has concluded that diet, rather than insufficient physical activity, is the leading cause of rising obesity rates in developed countries.

People coming off powerful weight-loss drugs such as Wegovy and Mounjaro should receive at least a year of follow-up care to prevent regaining the weight they’ve lost, new NHS guidance recommends.

A large proportion of children referred to NHS excess weight clinics in England are from the most deprived areas, and many are also living with neurodivergence or other serious health conditions, new research has revealed.

A daily pill for obesity could help people lose around twelve per cent of their body weight over a seventy-two-week period, according to trial results.

Eli Lilly and Company and the UK Government Department for Science, Innovation and Technology (DSIT) have announced a programme to develop innovative models of care for obesity.

Pakistan is facing a severe obesity epidemic, with 81 per cent of women and 74 per cent of men now classified as obese, health experts revealed at a seminar in Lahore.

New research from Germany has found that eating most of your daily calories later in the day may negatively affect metabolism and increase the risk of obesity and type 2 diabetes.

Patients taking weight loss drugs such as Ozempic and Wegovy may begin to regain weight within weeks of stopping the medication, a new study has found.

A new study has found that GLP-1 receptor agonists offer clear advantages over traditional treatments for idiopathic intracranial hypertension (IIH), with fewer headaches, visual symptoms and reduced need for medication or surgery.

Medications that target glucagon-like peptide-1 (GLP-1) could significantly improve testosterone levels and overall health outcomes in men and women diagnosed with obesity or type 2 diabetes (T2D), according to new research presented at the Endocrine Society’s 2025 annual meeting.